Skip to main content
Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
163.02
+0.77 (0.47%)
At close: Feb 21, 2025, 4:00 PM
165.15
+2.13 (1.31%)
After-hours: Feb 21, 2025, 7:24 PM EST

CRL Revenue

In the year 2024, Charles River Laboratories International had annual revenue of $4.05B, down -1.92%. Charles River Laboratories International had revenue of $1.00B in the quarter ending December 28, 2024, a decrease of -1.08%.

Revenue (ttm)
$4.05B
Revenue Growth
-1.92%
P/S Ratio
2.07
Revenue / Employee
$201,492
Employees
20,100
Market Cap
8.34B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 28, 20244.05B-79.42M-1.92%
Dec 30, 20234.13B153.35M3.86%
Dec 31, 20223.98B435.90M12.31%
Dec 25, 20213.54B616.23M21.08%
Dec 26, 20202.92B302.71M11.55%
Dec 28, 2019 Pro Pro Pro
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 26, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

CRL News

More News